V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210035702 | 210007780 | 0.99 | 106.5 | Adjuvant (A) | 2017-11-30 | 2017-12-09 | Methotrexate intrathecal | Y | N | 210014025 | METHOTREXATE INTRATHECAL |
| 210035703 | 210007789 | null | 19.3 | Curative (C) | 2018-07-01 | 2018-07-01 | Methotrexate Intrathecal (any age) | N | N | 210014046 | METHOTREXATE INTRATHECAL |
| 210035704 | 210007795 | 0 | 15.45 | null | 2015-04-02 | 2015-04-02 | Methotrexate Intrathecal (any age) | Y | N | 210014054 | METHOTREXATE INTRATHECAL |
| 210035705 | 210007804 | 0 | 76 | Curative (C) | 2016-09-15 | 2017-08-21 | Methotrexate intrathecal | Y | N | 210014064 | METHOTREXATE INTRATHECAL |
| 210035706 | 210007808 | 1.18 | 80.5 | Adjuvant (A) | 2016-04-02 | 2016-07-07 | Methotrexate intrathecal | N | N | 210014068 | METHOTREXATE INTRATHECAL |
| 210035707 | 210019152 | 1.75 | null | null | 2014-10-15 | 2014-10-29 | Methotrexate intrathecal | N | N | 210014072 | METHOTREXATE INTRATHECAL |
| 210035708 | 210007822 | 0 | 98.5 | Curative (C) | 2019-02-03 | 2018-08-23 | Methotrexate intrathecal | null | N | 210014084 | METHOTREXATE INTRATHECAL |
| 210035709 | 210007828 | null | 24.4 | Adjuvant (A) | 2015-01-24 | 2015-08-03 | Methotrexate intrathecal | N | N | 210014089 | METHOTREXATE INTRATHECAL |
| 210035710 | 210026287 | 1.71 | 18.25 | Curative (C) | 2018-02-01 | 2018-02-04 | Methotrexate Intrathecal (any age) | Y | N | 210014098 | METHOTREXATE INTRATHECAL |
| 210035711 | 210007841 | 0.87 | 23.95 | Curative (C) | 2017-03-20 | 2018-02-02 | Methotrexate intrathecal | N | null | 210014139 | METHOTREXATE INTRATHECAL |
| 210035712 | 210026291 | 0 | 52.2 | Curative (C) | 2016-02-24 | 2016-04-06 | Methotrexate intrathecal | Y | N | 210014166 | METHOTREXATE INTRATHECAL |
| 210035713 | 210007856 | 1.55 | 74 | null | null | 2014-05-16 | UKALL14- Ph 2 Induction | N | N | 210014168 | UKALL2014 |
| 210035714 | 210019168 | 1.74 | 52.7 | Curative (C) | 2015-12-09 | 2015-12-10 | UKALL 14 TRIAL | Y | N | 210014190 | UKALL2014 |
| 210035715 | 210019172 | 1.78 | 94.4 | Curative (C) | 2018-04-07 | 2018-04-08 | UKALL 14 TRIAL | Y | N | 210014253 | UKALL2014 |
| 210035716 | 210007886 | 1.75 | 90 | Curative (C) | 2016-08-15 | 2016-12-10 | UKALL14- Ph 2 Induction | 1 | null | 210014260 | UKALL2014 |
| 210035717 | 210007891 | 1.94 | 96.2 | Curative (C) | 2016-05-08 | 2016-10-18 | UKALL14- Ph 2 Induction | N | N | 210014273 | UKALL2014 |
| 210035718 | 210007900 | 1.64 | 73 | Curative (C) | null | 2015-05-04 | UKALL 14 TRIAL | N | null | 210014286 | UKALL2014 |
| 210035719 | 210007905 | 1.63 | 73.3 | Adjuvant (A) | 2016-02-01 | 2016-05-29 | UKALL14- Maintenance | Y | N | 210014295 | UKALL2014 |
| 210035720 | 210007915 | 1.67 | 85 | Curative (C) | 2014-08-16 | 2014-08-21 | UKALL14- Intens/CNS Proph +Imatinib | Y | N | 210014311 | UKALL2014 |
| 210035721 | 210030544 | 1.64 | 58.3 | Curative (C) | 2015-11-24 | 2016-02-21 | UKALL14- Ph 2 Induction | Y | N | 210014314 | UKALL2014 |
| 210035722 | 210007926 | 1.67 | 55.4 | Curative (C) | 2017-07-05 | 2017-07-10 | UKALL14- Ph 2 Induction + Imatinib | N | N | 210014320 | UKALL2014 |
| 210035723 | 210007939 | 1.55 | 54.4 | Disease modification (D) | 2015-11-05 | 2016-06-27 | UKALL14- Intens/CNS Proph | 01 | N | 210014366 | UKALL2014 |
| 210035724 | 210007947 | null | 71.2 | Curative (C) | 2015-10-07 | 2015-10-07 | UKALL14- Intens/CNS Proph | null | null | 210014387 | UKALL2014 |
| 210035725 | 210007957 | 1.57 | 80 | Curative (C) | 2013-09-23 | 2015-12-05 | UKALL14- Ph 2 Induction | Y | null | 210014406 | UKALL2014 |
| 210035726 | 210019193 | 1.82 | 101.7 | Curative (C) | 2014-11-08 | 2014-11-08 | UKALL14- Intens/CNS Proph | N | N | 210014446 | UKALL2014 |
| 210035727 | 210007968 | 1.83 | 141.9 | Curative (C) | 2016-04-02 | 2016-09-01 | UKALL14- Cons Cycle 1 | y | N | 210014450 | UKALL2014 |
| 210035729 | 210007979 | 1.6 | 67 | Curative (C) | 2015-03-23 | 2015-03-31 | UKALL14- Ph 1 Induction | Y | N | 210014466 | UKALL2014 |
| 210035730 | 210007988 | 1.66 | 103.5 | Curative (C) | null | 2013-09-07 | UKALL 14 TRIAL | Y | N | 210014481 | UKALL2014 |
| 210035731 | 210007994 | 1.95 | 97.8 | Curative (C) | 2013-08-05 | 2014-01-26 | UKALL14- Ph 1 Induction | Y | Y | 210014493 | UKALL2014 |
| 210035732 | 210007998 | 1.83 | 89.7 | Palliative (P) | 2018-02-23 | 2018-04-04 | UKALL14- Ph 2 Induction | Y | 0 | 210014497 | UKALL2014 |
| 210035734 | 210008017 | 1.87 | 60.7 | Curative (C) | 2016-01-04 | 2016-08-13 | UKALL14- Maintenance | 1 | N | 210014505 | UKALL2014 |
| 210035735 | 210008021 | 1.7 | 99.5 | Curative (C) | 2016-06-29 | 2016-07-01 | UKALL14- Intens/CNS Proph | null | N | 210014510 | UKALL2014 |
| 210035736 | 210008025 | null | 93.8 | Palliative (P) | 2014-03-18 | 2014-05-05 | UKALL14- Maintenance | Y | null | 210014515 | UKALL2014 |
| 210035737 | 210008030 | 1.61 | 43.6 | Curative (C) | 2016-01-01 | 2016-01-05 | UKALL14- Intens/CNS Proph | Y | N | 210014519 | UKALL2014 |
| 210035738 | 210030549 | 1.71 | 74.2 | Curative (C) | 2015-07-04 | 2016-03-19 | UKALL14- Cons Cycle 1 | N | N | 210014536 | UKALL2014 |
| 210035739 | 210008041 | null | 92 | Curative (C) | 2014-04-10 | 2014-10-28 | UKALL14- Cons Cycle 1 | Y | null | 210014554 | UKALL2014 |
| 210035740 | 210030550 | 1.76 | 83 | Curative (C) | null | 2019-03-28 | UKALL14- Cons Cycle 1 | Y | N | 210014561 | UKALL2014 |
| 210035741 | 210008050 | 1.92 | 85 | Curative (C) | 2014-12-23 | 2015-09-03 | UKALL 14 TRIAL | Y | N | 210014576 | UKALL2014 |
| 210035742 | 210008060 | 1.49 | 54.6 | Curative (C) | 2015-06-28 | 2015-09-22 | UKALL14- Intens/CNS Proph | 01 | N | 210014595 | UKALL2014 |
| 210035743 | 210008068 | 1.76 | 57.8 | Curative (C) | 2015-11-27 | 2015-11-28 | UKALL14- Maintenance | N | null | 210014607 | UKALL2014 |
| 210035746 | 210019235 | 1.62 | 118.2 | Curative (C) | 2013-11-01 | 2014-06-18 | UKALL14- Intens/CNS Proph | N | N | 210014626 | UKALL2014 |
| 210035747 | 210008090 | 1.63 | 71.7 | Curative (C) | 2013-07-18 | 2014-05-18 | UKALL14- Cons Cycle 1 | Y | null | 210014651 | UKALL2014 |
| 210035749 | 210008111 | 1.94 | 93.2 | Curative (C) | 2018-11-20 | 2019-01-12 | UKALL14- Ph 2 Induction + Imatinib | 1 | N | 210014674 | UKALL2014 |
| 210035750 | 210008116 | 1.54 | 78.3 | Curative (C) | null | 2017-05-15 | UKALL14- Maintenance | Y | N | 210014676 | UKALL2014 |
| 210035751 | 210008133 | 1.77 | 92.8 | Curative (C) | 2014-05-23 | 2014-11-23 | UKALL14- Cons Cycle 1 | 01 | N | 210014747 | UKALL2014 |
| 210035752 | 210019253 | 1.75 | 61.8 | Curative (C) | 2015-09-25 | 2016-03-02 | UKALL 14 TRIAL | Y | null | 210014757 | UKALL2014 |
| 210035753 | 210008153 | 1.72 | 67.8 | Curative (C) | 2018-03-07 | 2018-03-13 | UKALL14- Maintenance | 02 | N | 210014775 | UKALL2014 |
| 210035754 | 210008160 | 1.72 | 51.2 | Curative (C) | 2016-04-09 | 2017-03-03 | UKALL14- Maintenance | Y | N | 210014779 | UKALL2014 |
| 210035756 | 210008175 | 1.57 | 79.8 | Curative (C) | 2016-08-07 | 2017-03-20 | UKALL14- Maintenance | Y | N | 210014839 | UKALL2014 |
| 210035757 | 210008181 | 1.76 | 70.15 | Curative (C) | 2016-11-27 | 2016-11-27 | UKALL 14 TRIAL | 01 | N | 210014841 | UKALL2014 |